Schonfeld Strategic Advisors LLC

Position in RXST — RxSight, Inc.

CIK 1665241 NEW YORK, NY

Position in RXST

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,180,872

-$1,097,721 QoQ

Shares Held

191,700

-12.3% QoQ

Ownership

0.463%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Schonfeld Strategic Advisors LLC holds $205,253,916 across 27 Medical Devices names. RXST ranks #12 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BSX	Boston Scientific Corp	1,105,515	$69,371,066
2	SYK	Stryker Corp	118,195	$38,837,695
3	PODD	Insulet Corp	164,058	$34,425,930
4	MASI	Masimo Corp	117,297	$20,863,617
5	IRTC	iRhythm Holdings, Inc.	88,133	$10,401,456
6	DXCM	Dexcom Inc	152,930	$9,604,004
7	ATEC	Alphatec Holdings, Inc.	766,383	$8,338,247
8	ESTA	Establishment Labs Holdings Inc.	68,488	$3,888,748

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,180,872	191,700	-12.3%	Shares	Sole	2026-05-15
2025-12-31	$2,278,593	218,675	-60.8%	Shares	Sole	2026-02-17
2025-09-30	$5,012,832	557,601	+110.4%	Shares	Sole	2025-11-14
2025-06-30	$3,445,078	265,006	+60.6%	Shares	Sole	2025-08-14
2025-03-31	$4,165,467	164,969	-17.3%	Shares	Sole	2025-05-15
2024-12-31	$6,855,372	199,400	+315.4%	Shares	Sole	2025-02-14
2024-06-30	$2,888,400	48,004	-70.7%	Shares	Sole	2024-08-14
2024-03-31	$8,464,587	164,106	-13.1%	Shares	Sole	2024-05-15
2023-12-31	$7,616,246	188,895	+73.5%	Shares	Sole	2024-02-14
2023-09-30	$3,037,221	108,900	-25.9%	Shares	Sole	2023-11-14
2023-06-30	$4,230,720	146,900	+19.0%	Shares	Sole	2023-08-14
2023-03-31	$2,058,312	123,400	+158.2%	Shares	Sole	2023-05-15
2022-12-31	$605,626	47,800	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.